Tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate
C21H31FN2O4 — CID 151106555
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate
Tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate (PubChem CID 151106555) has the molecular formula C21H31FN2O4 and a molecular weight of 394.49 g/mol. Its IUPAC name is tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate |
|---|---|
| PubChem CID | 151106555 |
| Molecular Formula | C21H31FN2O4 |
| Molecular Weight | 394.49 g/mol |
| Exact Mass | 394.23 |
| IUPAC Name | tert-butyl (2S,5R)-4-[1-(4-fluorophenyl)-3-methoxy-3-oxopropyl]-2,5-dimethylpiperazine-1-carboxylate |
| SMILES | COC(=O)CC(c1ccc(F)cc1)N1C[C@H](C)N(C(=O)OC(C)(C)C)C[C@H]1C |
| InChI | InChI=1S/C21H31FN2O4/c1-14-13-24(20(26)28-21(3,4)5)15(2)12-23(14)18(11-19(25)27-6)16-7-9-17(22)10-8-16/h7-10,14-15,18H,11-13H2,1-6H3/t14-,15+,18?/m1/s1 |
| InChIKey | MPFOPFUAQGDNIM-ZCZZTKKGSA-N |
| XLogP | 3.76 |
| TPSA | 59.08 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 394.49 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151106555 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.